Industry Symposium

AMGEN Symposium
Thursday, December 11, 2025

1:10 PM – 1:15 PM
Welcome and Introduction
Prof. Dr. Oliver Weingärtner, Jena
Dr. Ursula Kassner, Berlin

1:15 PM – 1:40 PM
Risk Stratification and Prevention:
The Role of Early Intensive and Long-Term Lipid-Lowering Therapy
Dr. Julia Brandts, Aachen

1:40 PM – 2:05 PM
Risk Stratification and Prevention:
Lp(a) – Impact on Cardiovascular Risk and Future Treatment Options
Prof. Volker Schettler, Göttingen

2:05 PM – 2:10 PM
Summary, Conclusions and Closing Remarks
Prof. Dr. Oliver Weingärtner, Jena
Dr. Ursula Kassner, Berlin

---

Daiichi Sankyo Symposium
Friday, December 12, 2025

Topic: Diagnostics & Treatment of Hypercholesterinaemia 

Chair: Prof. Dr. Matthias Blüher, Leipzig / PD Dr. Ulrike Schatz, Dresden

12:00 PM – 12:05 PM
Introduction
PD Dr. Ulrike Schatz, Dresden

12:05 PM – 12:25 PM
When to initiate genetic testing in daily cardiology routine?
Prof. Dr. med. Wilhelm Haverkamp, Berlin

12:25 PM – 12:45 PM
Challenges & considerations in LDL-C Management: guidelines meet clinical practice
PD Dr. med. Ulrike Schatz, Dresden

12:45 PM – 12:50 PM
Closing remarks
Prof. Dr. Matthias Blüher, Leipzig

---

Novartis Symposium
Friday, December 12, 2025

11:40 – 11:45 a.m.
Welcome and introduction
Prof. Ulrich Laufs, Leipzig

11:45 – 12:10 a.m.
Making Lp(a) mandatory for personalized cardiovascular prevention
Prof. Borge Nordestgaard, Copenhagen

12:10 – 12:30 p.m.
Lp(a) therapiesat turningpoint: Evidenceand clinicalbenefitforhigh-riskpatients
Prof. Elisabeth Steinhagen-Thiessen, Berlin

12:30 – 12:50 p.m.
Management of ASCVD risk driver LDL-C
Dr. Ephraim Winzer, Dresden

12:50 – 01:00 p.m.
Audience Q&A and conclusion
Prof. Oliver Weingärtner (Chair) and all speakers